Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation

BACKGROUND: In 2010 a new diagnostic test for tuberculosis, Xpert MTB/RIF, received a conditional programmatic recommendation from WHO. Several model-based economic evaluations predicted that Xpert would be cost-effective across sub-Saharan Africa. We investigated the cost-effectiveness of Xpert in...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Lancet Glob Health
Autori principali: Vassall, Anna, Siapka, Mariana, Foster, Nicola, Cunnama, Lucy, Ramma, Lebogang, Fielding, Katherine, McCarthy, Kerrigan, Churchyard, Gavin, Grant, Alison, Sinanovic, Edina
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier Ltd 2017
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5471605/
https://ncbi.nlm.nih.gov/pubmed/28619229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2214-109X(17)30205-X
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi